We observed that for each dose of semaglutide, even with the small number of patients continuing therapy beyond 7 months, there was a trend to achieve greater weight loss with continued semaglutide (see supplementary)
14.2 Obstructive Sleep Apnea Studies in Adults with Obesity Overview of Study 5 and Study 6 The efficacy of ZEPBOUND for moderate to severe obstructive sleep apnea (OSA) (apnea-hypopnea index [AHI] 15) in patients with obesity (BMI 30 kg/m2) was evaluated in a master protocol clinical trial (NCT05412004) that included two randomized, double-blind, placebo-controlled trials (Study 5 and Study 6) of 52 weeks duration
PlexusDx patients typically start at lower doses and increase gradually over 16-20 weeks, a protocol proven to maximize weight loss while minimizing nausea
avoiding simple carbohydrates (cookies, candy, sweetened drinks, and ice cream)
I started BPC-157 peptides last week. Physio: [Googles furiously in real time] Raise your hand if peptide talk is suddenly part of every second consult BPC-157